Praktické lékárenství – 2E/2021

www.praktickelekarenstvi.cz e18 AKTUÁLNÍ FARMAKOTERAPIE Léčba hypertenze u cévních mozkových příhod PRAKTICKÉ LÉKÁRENSTVÍ Závěr Pečlivá kontrola arteriální hypertenze je přínosná v primární i sekundární prevenci CMP. Správně vedenou prevencí aterosklerotických vaskulárních onemocnění můžeme přispět ke snížení počtu příhod, zlepšení kvality a prodloužení života našich pacientů. LITERATURA 1. Donkor ES. Stroke in the 21 st Century: A Snapshot of the Burden, Epidemiology, and Qu- ality of Life. Stroke Res Treat. 2018; 2018: 3238165. doi: 10.1155/2018/3238165. 2. Kotseva K, De Backer G, De Bacquer D. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Car- diology ESC-EORP EUROASPIRE V registry. European Journal of Preventive Cardiology 2019; 26(8). doi: https://doi.org/10.1177/2047487318825350. 3. Lüscher TF. Epidemiology of cardiovascular disease: the new ESC Atlas and bey- ond European Heart Journal 2018; 39(7): 489–492. doi: https://doi.org/10.1093/eurhe- artj/ehy070 4. Samsa GP, Bian J, Lipscomb J, Matchar DB. Epidemiology of recurrent cerebral infarcti- on: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke 1999; 30: 338–349. 5. Feng W, Hendry HM, Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology 2010; 74(7). doi: https://doi.org/10.1212/ WNL.0b013e3181cff776. 6. Zanchetti A, Liu L, Mancia G, et al. Blood pressure and low-density lipoprotein-choleste- rol lowering for prevention of strokes and cognitive decline: a review of available trial evi- dence. J Hypertens 2014; 32: 1741–1750. 7. Cífková R, Wohlfahrt P, Krajčoviechová A, et al. Blood pressure control and risk profile in poststroke survivors: a comparison with the general population. J Hypertens. 2015; 33(10): 2107–2114. doi: 10.1097/HJH.0000000000000660. PMID: 26200884. 8. Hong SK. Blood Pressure Management for Stroke Prevention and in Acute Stroke. J Stro- ke 2017; 19(2): 152–165. doi: 10.5853/jos.2017.00164. 9. Kohok DD, Sico JJ, Bae F, et al. Post-stroke hypertension control and receipt of health care services among veterans. JCH 2018; 20(2): 382–387. doi: https://doi.org/10.1111/jch.13194 10. Ahmed N, Audebert H, Turc G, et al. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018. Eu- ropean Stroke Journal 2019; 4(4): 307–317. doi: https://doi.org/10.1177/2396987319863606. 11. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eu- ropean Heart Journal 2018; 39(33): 3021–3104. doi: https://doi.org/10.1093/eurheartj/ehy339. 12. Williamson JD, Supiano MA, Applegate WB, et al. SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 2016; 315: 2673–2682. 13. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovas- cular disease and death: a systematic review and meta-analysis. Lancet 2016; 387: 957–967. 14. Emdin CA, Rahimi K, Neal B, et al. Blood pressure lowering in type 2 diabetes: a syste- matic review and meta-analysis. JAMA 2015; 313: 603–615. 15. PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pres- sure-lowering regimen among 6,105 individuals with previous stroke or transient ischae- mic attack. Lancet. 2001; 358(9287): 1033–1041.